Navigation Links
Oral Drug Helps Prevent Clotting After Hip Replacement
Date:6/25/2008

Daily dose of rivaroxaban cut risk of venous thromboembolism, study finds

WEDNESDAY, June 25 (HealthDay News) -- Extended use of the oral drug rivaroxaban helps prevent potentially fatal blood clots after hip replacement surgery, British researchers say.

The risk of venous thromboembolism (VTE) is high after total hip replacement, and the risk can persist after a patient leaves hospital. Current guidelines recommend patients receive a heparin-based preventive drug such as enoxaparin (Lovenox) for a minimum of 10 days, and up to 35 days, after surgery. However, this preventive treatment is not used much after patients leave hospital, according to background information in the study.

The researchers at the London School of Medicine and Dentistry and the Thrombosis Research Institute compared the new oral antithrombotic drug rivaroxaban (Xarelto) with enoxaparin in the treatment of hip replacement patients.

In the randomized, controlled trial, 1,252 patients received 10 milligrams of oral rivaroxaban once daily for 31 to 39 days, followed by placebo injection for 10 to 14 days, while 1,257 patients received 40 milligram once-daily injections of enoxaparin for 10 to 14 days, followed by placebo tablets for 31 to 39 days.

The completed analysis of 864 patients in the rivaroxaban group and 869 patients in the enoxaparin group found that patients in the enoxaparin group were more than four times as likely to suffer deep vein thrombosis, nonfatal pulmonary embolism, or die than patients in the rivaroxaban group -- 9.3 percent versus 2 percent. Both groups had similar rates of bleeding events during treatment.

"Extended thromboprophylaxis with rivaroxaban was significantly more effective than short-term enoxaparin plus placebo for the prevention of venous thromboembolism, including symptomatic events, in patients undergoing total hip arthroplasty [replacement]," the researchers concluded.

The study was released online Wednesday by The Lancet and will be published in an upcoming issue.

"With superior efficacy, no compromise in safety, and a convenient once-daily regimen, rivaroxaban seems an obvious choice for simplified thromboprophylaxis after hip or knee arthroplasty [replacement]," Dr. John Eikelboom and Jeffrey Weitz, of McMaster University in Hamilton, Ontario, Canada, wrote in an accompanying editorial.

More information

The American Academy of Orthopaedic Surgeons has more about total hip replacement.



-- Robert Preidt



SOURCE: The Lancet, news release, June 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Heel Ultrasound Helps Detect Fracture Risk
2. Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats
3. Pro Baseball Helps Keep Skin Cancer From Scoring
4. Caregiverlist.com Helps Families Find Quality Senior Care
5. World Renowned Hand Surgeon Helps Patients Conquer Joint Discomfort Naturally
6. Nature Made SAM-e Complete Helps Americans Find Their Good Moods
7. Gene Therapy Helps Dogs Stricken With Cancer
8. New study shows American Cancer Society program helps employers
9. Estrogen therapy helps or hurts the brain depending on reproductive status
10. Online Scheduler Helps Track Kids Shots
11. MassMutual Announces Web Site Enhancement That Helps Employees Save for Retirement Sooner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... VA (PRWEB) , ... May 03, 2016 , ... ... provider of innovative information technology (IT) solutions and digital consulting services to the ... Information Technology Services (EITS) Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support ...
(Date:5/3/2016)... ... May 03, 2016 , ... Huntington Beach orthopedic doctor , ... procedure that can be used to diagnose and treat joint problems. During this procedure, ... instruments include a special lighting system and lens that illuminate and magnify the various ...
(Date:5/3/2016)... ... May 03, 2016 , ... Branches, Inc. is proud ... & Climb children and youth programs in South Miami. Macy’s is a wonderful community ... The Grow Program provides afterschool tutoring, mentoring, enrichment and academic support to elementary students ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Finding the right way to address a ... the healthcare industry is now getting on board. , “You do the right thing, at ... cost of care goes down, not up,” said Leonard M. Fromer, MD, FAAFP, from Group ...
(Date:5/3/2016)... ... , ... LunchSkins is changing the future of ocean plastic pollution ... away plastic baggies. The mission-driven bags give back to global leaders in the fight ... mission is all about reducing global plastic waste and we’ve teamed up with ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology: